Testicular immunohistochemical and Ultrastructural changes associated with chronic cholestasis in rats: Effect of ursodeoxycholic acid

Testicular atrophy has been commonly reported in patients with chronic liver diseases. Ursodeoxycholic acid is the most widely used drug for the treatment of many liver diseases. However, its effect on testicular ultrastructure associated with chronic cholestasis has never been studied. Thus, this s...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Life sciences (1973) 2015-09, Vol.136, p.52-59
1. Verfasser: Mahmoud, Yomna I.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 59
container_issue
container_start_page 52
container_title Life sciences (1973)
container_volume 136
creator Mahmoud, Yomna I.
description Testicular atrophy has been commonly reported in patients with chronic liver diseases. Ursodeoxycholic acid is the most widely used drug for the treatment of many liver diseases. However, its effect on testicular ultrastructure associated with chronic cholestasis has never been studied. Thus, this study aimed to assess how chronic obstructive jaundice affects the testicular ultrastructure and whether it affects the androgen receptor or the proliferating cell nuclear antigen. The role of ursodeoxycholic acid was also investigated. Cholestasis was induced by bile duct ligation. Samples were collected 4weeks postoperative. Testicular changes were assessed using immunohistochemistry and transmission electron microscopy. Chronic cholestasis resulted in testicular atrophy evidenced by shrinkage and deformation of seminiferous tubules, thickening of peritubular boundaries, vacuolation, disorganization of germ cells, and maturation arrest. This was accompanied by decreased immunoreactivity of androgen receptors and proliferating cell nuclear antigen. Administration of ursodeoxycholic acid improved the testicular morphology and reversed cholestasis-induced immunohistochemical and ultrastructural changes. Ursodeoxycholic acid can improve the testicular ultrastructure and restore the spermatogenic process in rats with chronic cholestasis. These findings support the clinical application of ursodeoxycholic acid in cholestatic patients especially those with hypogonadism.
doi_str_mv 10.1016/j.lfs.2015.05.027
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1706576422</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0024320515003422</els_id><sourcerecordid>1706576422</sourcerecordid><originalsourceid>FETCH-LOGICAL-c353t-9db4e404379824c11cef1d91cc5da788aed971824eb5afd0d9a27f8427c117bc3</originalsourceid><addsrcrecordid>eNp9kM9OHDEMhyNUBFvgAXqpcuxltknmT2baU4VoqYTEBc5R1nHYrGYmNM4UeIE-N1kt7bGSJUvO55-cj7EPUqylkN3n3Xr0tFZCtmtRSukjtpK9HirR1fIdWwmhmqpWoj1l74l2Qoi21fUJO1WdbOTQDyv25w4pB1hGm3iYpmWO20A5whanAHbkdnb8fszJUk4L5CWVGWzt_IDELVGEYDM6_hTytsxTnAOUHseSaikQDzNPNtMXfuU9QubR8yVRdBifX_ZcwS0Ed86OvR0JL976Gbv_fnV3eV3d3P74efntpoK6rXM1uE2DjWhqPfSqASkBvXSDBGid1X1v0Q1alifctNY74QartO8bpQurN1CfsU-H3McUfy3lSDMFAhxHO2NcyEgtulZ3jVIFlQcUUiRK6M1jCpNNL0YKs9dvdqboN3v9RpRSuux8fItfNhO6fxt_fRfg6wHA8snfAZMhCDgDupCKHuNi-E_8KzQ2mao</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1706576422</pqid></control><display><type>article</type><title>Testicular immunohistochemical and Ultrastructural changes associated with chronic cholestasis in rats: Effect of ursodeoxycholic acid</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Mahmoud, Yomna I.</creator><creatorcontrib>Mahmoud, Yomna I.</creatorcontrib><description>Testicular atrophy has been commonly reported in patients with chronic liver diseases. Ursodeoxycholic acid is the most widely used drug for the treatment of many liver diseases. However, its effect on testicular ultrastructure associated with chronic cholestasis has never been studied. Thus, this study aimed to assess how chronic obstructive jaundice affects the testicular ultrastructure and whether it affects the androgen receptor or the proliferating cell nuclear antigen. The role of ursodeoxycholic acid was also investigated. Cholestasis was induced by bile duct ligation. Samples were collected 4weeks postoperative. Testicular changes were assessed using immunohistochemistry and transmission electron microscopy. Chronic cholestasis resulted in testicular atrophy evidenced by shrinkage and deformation of seminiferous tubules, thickening of peritubular boundaries, vacuolation, disorganization of germ cells, and maturation arrest. This was accompanied by decreased immunoreactivity of androgen receptors and proliferating cell nuclear antigen. Administration of ursodeoxycholic acid improved the testicular morphology and reversed cholestasis-induced immunohistochemical and ultrastructural changes. Ursodeoxycholic acid can improve the testicular ultrastructure and restore the spermatogenic process in rats with chronic cholestasis. These findings support the clinical application of ursodeoxycholic acid in cholestatic patients especially those with hypogonadism.</description><identifier>ISSN: 0024-3205</identifier><identifier>EISSN: 1879-0631</identifier><identifier>DOI: 10.1016/j.lfs.2015.05.027</identifier><identifier>PMID: 26141989</identifier><language>eng</language><publisher>Netherlands: Elsevier Inc</publisher><subject>Androgen receptor ; Animals ; Cholagogues and Choleretics - pharmacology ; Cholagogues and Choleretics - therapeutic use ; Cholestasis ; Cholestasis - complications ; Cholestasis - drug therapy ; Cholestasis - metabolism ; Drug Evaluation, Preclinical ; Immunohistochemistry ; Male ; Proliferating cell nuclear antigen ; Rat ; Rats, Wistar ; Spermatogenesis - drug effects ; Testicular Diseases - etiology ; Testicular Diseases - metabolism ; Testicular Diseases - prevention &amp; control ; Testis ; Testis - drug effects ; Testis - metabolism ; Testis - pathology ; Ultrastructure ; Ursodeoxycholic acid ; Ursodeoxycholic Acid - pharmacology ; Ursodeoxycholic Acid - therapeutic use</subject><ispartof>Life sciences (1973), 2015-09, Vol.136, p.52-59</ispartof><rights>2015</rights><rights>Copyright © 2015. Published by Elsevier Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c353t-9db4e404379824c11cef1d91cc5da788aed971824eb5afd0d9a27f8427c117bc3</citedby><cites>FETCH-LOGICAL-c353t-9db4e404379824c11cef1d91cc5da788aed971824eb5afd0d9a27f8427c117bc3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.lfs.2015.05.027$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26141989$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mahmoud, Yomna I.</creatorcontrib><title>Testicular immunohistochemical and Ultrastructural changes associated with chronic cholestasis in rats: Effect of ursodeoxycholic acid</title><title>Life sciences (1973)</title><addtitle>Life Sci</addtitle><description>Testicular atrophy has been commonly reported in patients with chronic liver diseases. Ursodeoxycholic acid is the most widely used drug for the treatment of many liver diseases. However, its effect on testicular ultrastructure associated with chronic cholestasis has never been studied. Thus, this study aimed to assess how chronic obstructive jaundice affects the testicular ultrastructure and whether it affects the androgen receptor or the proliferating cell nuclear antigen. The role of ursodeoxycholic acid was also investigated. Cholestasis was induced by bile duct ligation. Samples were collected 4weeks postoperative. Testicular changes were assessed using immunohistochemistry and transmission electron microscopy. Chronic cholestasis resulted in testicular atrophy evidenced by shrinkage and deformation of seminiferous tubules, thickening of peritubular boundaries, vacuolation, disorganization of germ cells, and maturation arrest. This was accompanied by decreased immunoreactivity of androgen receptors and proliferating cell nuclear antigen. Administration of ursodeoxycholic acid improved the testicular morphology and reversed cholestasis-induced immunohistochemical and ultrastructural changes. Ursodeoxycholic acid can improve the testicular ultrastructure and restore the spermatogenic process in rats with chronic cholestasis. These findings support the clinical application of ursodeoxycholic acid in cholestatic patients especially those with hypogonadism.</description><subject>Androgen receptor</subject><subject>Animals</subject><subject>Cholagogues and Choleretics - pharmacology</subject><subject>Cholagogues and Choleretics - therapeutic use</subject><subject>Cholestasis</subject><subject>Cholestasis - complications</subject><subject>Cholestasis - drug therapy</subject><subject>Cholestasis - metabolism</subject><subject>Drug Evaluation, Preclinical</subject><subject>Immunohistochemistry</subject><subject>Male</subject><subject>Proliferating cell nuclear antigen</subject><subject>Rat</subject><subject>Rats, Wistar</subject><subject>Spermatogenesis - drug effects</subject><subject>Testicular Diseases - etiology</subject><subject>Testicular Diseases - metabolism</subject><subject>Testicular Diseases - prevention &amp; control</subject><subject>Testis</subject><subject>Testis - drug effects</subject><subject>Testis - metabolism</subject><subject>Testis - pathology</subject><subject>Ultrastructure</subject><subject>Ursodeoxycholic acid</subject><subject>Ursodeoxycholic Acid - pharmacology</subject><subject>Ursodeoxycholic Acid - therapeutic use</subject><issn>0024-3205</issn><issn>1879-0631</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kM9OHDEMhyNUBFvgAXqpcuxltknmT2baU4VoqYTEBc5R1nHYrGYmNM4UeIE-N1kt7bGSJUvO55-cj7EPUqylkN3n3Xr0tFZCtmtRSukjtpK9HirR1fIdWwmhmqpWoj1l74l2Qoi21fUJO1WdbOTQDyv25w4pB1hGm3iYpmWO20A5whanAHbkdnb8fszJUk4L5CWVGWzt_IDELVGEYDM6_hTytsxTnAOUHseSaikQDzNPNtMXfuU9QubR8yVRdBifX_ZcwS0Ed86OvR0JL976Gbv_fnV3eV3d3P74efntpoK6rXM1uE2DjWhqPfSqASkBvXSDBGid1X1v0Q1alifctNY74QartO8bpQurN1CfsU-H3McUfy3lSDMFAhxHO2NcyEgtulZ3jVIFlQcUUiRK6M1jCpNNL0YKs9dvdqboN3v9RpRSuux8fItfNhO6fxt_fRfg6wHA8snfAZMhCDgDupCKHuNi-E_8KzQ2mao</recordid><startdate>20150901</startdate><enddate>20150901</enddate><creator>Mahmoud, Yomna I.</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20150901</creationdate><title>Testicular immunohistochemical and Ultrastructural changes associated with chronic cholestasis in rats: Effect of ursodeoxycholic acid</title><author>Mahmoud, Yomna I.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c353t-9db4e404379824c11cef1d91cc5da788aed971824eb5afd0d9a27f8427c117bc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Androgen receptor</topic><topic>Animals</topic><topic>Cholagogues and Choleretics - pharmacology</topic><topic>Cholagogues and Choleretics - therapeutic use</topic><topic>Cholestasis</topic><topic>Cholestasis - complications</topic><topic>Cholestasis - drug therapy</topic><topic>Cholestasis - metabolism</topic><topic>Drug Evaluation, Preclinical</topic><topic>Immunohistochemistry</topic><topic>Male</topic><topic>Proliferating cell nuclear antigen</topic><topic>Rat</topic><topic>Rats, Wistar</topic><topic>Spermatogenesis - drug effects</topic><topic>Testicular Diseases - etiology</topic><topic>Testicular Diseases - metabolism</topic><topic>Testicular Diseases - prevention &amp; control</topic><topic>Testis</topic><topic>Testis - drug effects</topic><topic>Testis - metabolism</topic><topic>Testis - pathology</topic><topic>Ultrastructure</topic><topic>Ursodeoxycholic acid</topic><topic>Ursodeoxycholic Acid - pharmacology</topic><topic>Ursodeoxycholic Acid - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mahmoud, Yomna I.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Life sciences (1973)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mahmoud, Yomna I.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Testicular immunohistochemical and Ultrastructural changes associated with chronic cholestasis in rats: Effect of ursodeoxycholic acid</atitle><jtitle>Life sciences (1973)</jtitle><addtitle>Life Sci</addtitle><date>2015-09-01</date><risdate>2015</risdate><volume>136</volume><spage>52</spage><epage>59</epage><pages>52-59</pages><issn>0024-3205</issn><eissn>1879-0631</eissn><abstract>Testicular atrophy has been commonly reported in patients with chronic liver diseases. Ursodeoxycholic acid is the most widely used drug for the treatment of many liver diseases. However, its effect on testicular ultrastructure associated with chronic cholestasis has never been studied. Thus, this study aimed to assess how chronic obstructive jaundice affects the testicular ultrastructure and whether it affects the androgen receptor or the proliferating cell nuclear antigen. The role of ursodeoxycholic acid was also investigated. Cholestasis was induced by bile duct ligation. Samples were collected 4weeks postoperative. Testicular changes were assessed using immunohistochemistry and transmission electron microscopy. Chronic cholestasis resulted in testicular atrophy evidenced by shrinkage and deformation of seminiferous tubules, thickening of peritubular boundaries, vacuolation, disorganization of germ cells, and maturation arrest. This was accompanied by decreased immunoreactivity of androgen receptors and proliferating cell nuclear antigen. Administration of ursodeoxycholic acid improved the testicular morphology and reversed cholestasis-induced immunohistochemical and ultrastructural changes. Ursodeoxycholic acid can improve the testicular ultrastructure and restore the spermatogenic process in rats with chronic cholestasis. These findings support the clinical application of ursodeoxycholic acid in cholestatic patients especially those with hypogonadism.</abstract><cop>Netherlands</cop><pub>Elsevier Inc</pub><pmid>26141989</pmid><doi>10.1016/j.lfs.2015.05.027</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0024-3205
ispartof Life sciences (1973), 2015-09, Vol.136, p.52-59
issn 0024-3205
1879-0631
language eng
recordid cdi_proquest_miscellaneous_1706576422
source MEDLINE; ScienceDirect Journals (5 years ago - present)
subjects Androgen receptor
Animals
Cholagogues and Choleretics - pharmacology
Cholagogues and Choleretics - therapeutic use
Cholestasis
Cholestasis - complications
Cholestasis - drug therapy
Cholestasis - metabolism
Drug Evaluation, Preclinical
Immunohistochemistry
Male
Proliferating cell nuclear antigen
Rat
Rats, Wistar
Spermatogenesis - drug effects
Testicular Diseases - etiology
Testicular Diseases - metabolism
Testicular Diseases - prevention & control
Testis
Testis - drug effects
Testis - metabolism
Testis - pathology
Ultrastructure
Ursodeoxycholic acid
Ursodeoxycholic Acid - pharmacology
Ursodeoxycholic Acid - therapeutic use
title Testicular immunohistochemical and Ultrastructural changes associated with chronic cholestasis in rats: Effect of ursodeoxycholic acid
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T11%3A20%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Testicular%20immunohistochemical%20and%20Ultrastructural%20changes%20associated%20with%20chronic%20cholestasis%20in%20rats:%20Effect%20of%20ursodeoxycholic%20acid&rft.jtitle=Life%20sciences%20(1973)&rft.au=Mahmoud,%20Yomna%20I.&rft.date=2015-09-01&rft.volume=136&rft.spage=52&rft.epage=59&rft.pages=52-59&rft.issn=0024-3205&rft.eissn=1879-0631&rft_id=info:doi/10.1016/j.lfs.2015.05.027&rft_dat=%3Cproquest_cross%3E1706576422%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1706576422&rft_id=info:pmid/26141989&rft_els_id=S0024320515003422&rfr_iscdi=true